CE Mark for RECELL ® GO is an important milestone for AVITA Medical and for patients,” said Jim Corbett, Chief Executive Officer of AVITA Medical. “It enables us to bring this option to burn centers ...

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced that the successful commercial launch of Ryoncil ® (remestemcel-L-rknd), ...

Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today ...

Dr. Xie Fangmin, founder, chairman, and CEO of Fangzhou, remarked: “This launch is not simply a product milestone, but a strategic inflection point. XS LLM provides the technical foundation to embed ...